Israeli drugmaker Teva in 3.6-billion-euro German deal
(FRANKFURT) - Israeli pharma giant Teva said Thursday it had signed a deal to buy Ratiopharm, Germany's second largest generic drugs producer, for 3.6 billion euros (4.9 billion dollars).
"The acquisition will position Teva as the leading generic pharmaceutical company in Europe," the Jerusalem-based drugmaker said, boosting yearly sales in Europe to 5.2 billion dollars from 3.3 billion dollars at present.
Text and Picture Copyright 2010 AFP. All other Copyright 2010 EUbusiness Ltd. All rights reserved. This material is intended solely for personal use. Any other reproduction, publication or redistribution of this material without the written agreement of the copyright owner is strictly forbidden and any breach of copyright will be considered actionable.